Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy, safety, and pharmacokinetics of APT-1011 in eosinophilic esophagitis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• APT-1011

Snippet

Sponsor: Adare Pharmaceuticals, Inc. | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED | Results posted: 2023-04-26